Michael Lee Reed - 31 Jul 2026 Form 4 Insider Report for Nutex Health Inc. (NUTX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Aug 2026, 09:59:01 UTC
Prior SEC filing
24 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Reed

Key filing fact

Michael Lee Reed filed Form 4 for Nutex Health Inc. (NUTX) on 03 Aug 2026.

Key facts

  • This page summarizes Michael Lee Reed's Form 4 filing for Nutex Health Inc. (NUTX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Aug 2026, 09:59.

Change

  • Previous filing in this sequence was filed on 24 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001922252 Primary reporting owner

Reed Michael Lee

Relationship
Director
Address
1776 YORKTOWN STREET SUITE 700, C/O NUTEX HEALTH INC., HOUSTON
Signature
/s/ Michael Reed
Signature date
03 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUTX transaction

Common Stock

Options Exercise

Transaction value
Shares
+603
Change %
+900%
Price
$0.000000*
Shares after
670
Date
31 Jul 2026
Ownership
See note (2)
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted stock units convert into common shares on a one-for-one basis.

Footnote F2

Michael L Reed Trust IRA ("MLRTIRA"), the direct beneficial owner of 67 shares of Common Stock. Michael L Reed, the sole trustee of MLRTIRA, is the indirect beneficial owner of such shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .